Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Antibiotics (Basel) ; 12(2)2023 Feb 09.
Article in English | MEDLINE | ID: mdl-36830274

ABSTRACT

Visceral leishmaniasis (VL), a vector-borne parasitic disease caused by Leishmania donovani and L. infantum (Kinetoplastida), affects humans and dogs, being fatal unless treated. Miltefosine (MIL) is the only oral medication for VL and is considered a first choice drug when resistance to antimonials is present. Comorbidity and comedication are common in many affected patients but the relationship between microbiome composition, drugs administered and their pharmacology is still unknown. To explore the effect of clindamycin on the intestinal microbiome and the availability and distribution of MIL in target organs, Syrian hamsters (120-140 g) were inoculated with L. infantum (108 promastigotes/animal). Infection was maintained for 16 weeks, and the animals were treated with MIL (7 days, 5 mg/kg/day), clindamycin (1 mg/kg, single dose) + MIL (7 days, 5 mg/kg/day) or kept untreated. Infection was monitored by ELISA and fecal samples (16 wpi, 18 wpi, end point) were analyzed to determine the 16S metagenomic composition (OTUs) of the microbiome. MIL levels were determined by LC-MS/MS in plasma (24 h after the last treatment; end point) and target organs (spleen, liver) (end point). MIL did not significantly affect the composition of intestinal microbiome, but clindamycin provoked a transient albeit significant modification of the relative abundance of 45% of the genera, including Ruminococcaceae UCG-014, Ruminococcus 2; Bacteroides and (Eubacterium) ruminantium group, besides its effect on less abundant phyla and families. Intestinal dysbiosis in the antibiotic-treated animals was associated with significantly lower levels of MIL in plasma, though not in target organs at the end of the experiment. No clear relationship between microbiome composition (OTUs) and pharmacological parameters was found.

2.
Parasit Vectors ; 15(1): 468, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-36522762

ABSTRACT

BACKGROUND: Visceral leishmaniasis (VL) is the most severe form of all leishmanial infections and is caused by infection with protozoa of Leishmania donovani and Leishmania infantum. This parasitic disease occurs in over 80 countries and its geographic distribution is on the rise. Although the interaction between the intestinal microbiome and the immune response has been established in several pathologies, it has not been widely studied in leishmaniasis. The Syrian hamster is the most advanced laboratory model for developing vaccines and new drugs against VL. In the study reported here, we explored the relationship between the intestinal microbiome and infection with L. infantum in this surrogate host. METHODS: Male Syrian hamsters (120-140 g) were inoculated with 108 promastigotes of a canine-derived L. infantum strain or left as uninfected control animals. Infection was maintained for 19 weeks (endpoint) and monitored by an immunoglobulin G (IgG) enyzme-linked immunosorbent assay throughout the experiment. Individual faecal samples, obtained at weeks 16, 18 and 19 post-inoculation, were analysed to determine the 16S metagenomic composition (the operational taxonomic units [OTUs] of the intestinal microbiome and the comparison between groups were FDR (false discovery rate)-adjusted). RESULTS: Leishmania infantum infection elicited moderate clinical signs and lesions and a steady increase in specific anti-Leishmania serum IgG. The predominant phyla (Firmicutes + Bacteriodetes: > 90%), families (Muribaculaceae + Lachnospiraceae + Ruminococcaceae: 70-80%) and genera found in the uninfected hamsters showed no significant variations throughout the experiment. Leishmania infantum infection provoked a slightly higher-albeit non-significant-value for the Firmicutes/Bacteriodetes ratio but no notable differences were found in the relative abundance or diversity of phyla and families. The microbiome of the infected hamsters was enriched in CAG-352, whereas Lachnospiraceae UCG-004, the [Eubacterium] ventriosum group and Allobaculum were less abundant. CONCLUSIONS: The lack of extensive significant differences between hamsters infected and uninfected with L. infantum in the higher taxa (phyla, families) and the scarce variation found, which was restricted to genera with a low relative abundance, suggest that there is no clear VL infection-intestinal microbiome axis in hamsters. Further studies are needed (chronic infections, co-abundance analyses, intestinal sampling, functional analysis) to confirm these findings and to determine more precisely the possible relationship between microbiome composition and VL infection.


Subject(s)
Gastrointestinal Microbiome , Leishmania infantum , Leishmaniasis, Visceral , Leishmaniasis , Cricetinae , Dogs , Male , Animals , Mesocricetus , Leishmaniasis, Visceral/parasitology , Leishmaniasis/parasitology , Immunoglobulin G
3.
Microorganisms ; 9(12)2021 Dec 02.
Article in English | MEDLINE | ID: mdl-34946102

ABSTRACT

Leishmaniasis is a vector-borne parasitic disease caused by Leishmania species. The disease affects humans and animals, particularly dogs, provoking cutaneous, mucocutaneous, or visceral processes depending on the Leishmania sp. and the host immune response. No vaccine for humans is available, and the control relies mainly on chemotherapy. However, currently used drugs are old, some are toxic, and the safer presentations are largely unaffordable by the most severely affected human populations. Moreover, its efficacy has shortcomings, and it has been challenged by the growing reports of resistance and therapeutic failure. This manuscript presents an overview of the currently used drugs, the prevailing model to develop new antileishmanial drugs and its low efficiency, and the impact of deconstruction of the drug pipeline on the high failure rate of potential drugs. To improve the predictive value of preclinical research in the chemotherapy of leishmaniasis, several proposals are presented to circumvent critical hurdles-namely, lack of common goals of collaborative research, particularly in public-private partnership; fragmented efforts; use of inadequate surrogate models, especially for in vivo trials; shortcomings of target product profile (TPP) guides.

4.
BMC Vet Res ; 15(1): 333, 2019 Sep 18.
Article in English | MEDLINE | ID: mdl-31533718

ABSTRACT

BACKGROUND: Haemonchosis is one of the most economically important parasitic diseases affecting small ruminants all over the world. Chemotherapeutic control has several shortcomings (limited anthelmintic arsenal, frequent resistance) and is hardly affordable by many farm economies. A recombinant antigen (rHc23) was shown to induce significant protection in vaccination trials with single dose challenges and different adjuvants. RESULTS: Lambs were vaccinated with 100 µg rHc23/dose + bacterial immunostimulant (BI) (LPS from Escherichia coli + Propionibacterium acnes extract) (days - 2, 0, 7 and 14) and subjected to a trickle infection with two dosages [6x, 1000 infective larvae (L3) or 6x, 2000 L3]. Vaccinated lambs showed a significant antibody response against rHc23 and Haemonchus contortus soluble extract as assessed by ELISA and Western blot (WB). Fecal egg counts (epg) along the experiment of vaccinated and BI treated lambs were significantly reduced. All vaccinated animals showed total egg output and abomasal helminth burdens (median, average) lower than those from unvaccinated or BI-treated animals lambs although differences were not statistically significant. CONCLUSIONS: Vaccination with 100 µg rHc23/dose + BI against H.contortus trickle infections apparently induced lower epg values and helminth burdens at the end of the experiment. Intragroup individual variations did not allow to obtain conclusive results and more research is needed including adjuvants and larger groups of animals to validate the potential value of rHc23 as candidate to develop a recombinant vaccine for lambs haemonchosis.


Subject(s)
Antigens, Helminth/immunology , Haemonchiasis/veterinary , Sheep Diseases/parasitology , Abomasum/parasitology , Adjuvants, Immunologic/administration & dosage , Animals , Female , Haemonchiasis/immunology , Haemonchiasis/prevention & control , Haemonchus/immunology , Parasite Egg Count/veterinary , Recombinant Proteins/immunology , Sheep , Sheep Diseases/immunology , Sheep Diseases/prevention & control , Sheep, Domestic , Vaccination/veterinary
5.
PLoS One ; 13(3): e0193118, 2018.
Article in English | MEDLINE | ID: mdl-29513692

ABSTRACT

Haemonchus contortus is the most pathogenic gastrointestinal helminth of small ruminants. Natural or experimental repeated infections and several native antigens confer a partially protective immune response but vaccination with subunit antigens has been elusive. Promising results have been obtained with a recombinant form of a somatic antigen (rHc23). In this paper we present the results obtained in vaccination trials in lambs using two dosages of rHc23 and standard adjuvants. Six-months old Manchego females lambs were vaccinated with rHc23 (50 or 200 µg/dose) adjuvanted with 1mL aluminum hydroxide on days -42, -28 and -14 or with 200 µg/dose rHc23 and 5 mg Quil A on days -49, -28 and -7. Control lambs were kept receiving only the adjuvants the same days or no treatment. Moreover one group did not receive any treatment or infection. On day 0 vaccinated lambs, untreated animals and those receiving the adjuvant were infected per os with a monospecific single infection of 4000 L3 of H. contortus. Infection was kept for 58 days and follow-up included the determination of serum specific antibody response (ELISA, WB), hematological parameters (eosinophil counts, hematocrit) and fecal egg counts (epg). Absence of hematocrit alterations, reduction of helminth's eggs output and abomasal parasite burden at the end of the experiment were the efficacy criteria of vaccination with the recombinant. Immunization with both adjuvants and antigen dosages elicited strong antibody responses particularly with Quil A. Vaccinated groups showed significant reduction of fecal egg excretion and abomasal helminth burdens. Highest protection of lambs against challenge was achieved with aluminum hydroxide and 200 µg/dose rHc23 with a reduction of over 70% of the abomasal burden and over 80% of fecal egg output. Results suggest that rHc23 could be a valuable recombinant candidate for vaccination against haemonchosis. No clear relationship was found between antibody levels and protection this pointing towards involvement of both humoral and cellular components in the protective response elicited by rHc23.


Subject(s)
Antigens, Helminth/immunology , Haemonchus/immunology , Nematode Infections/immunology , Sheep Diseases/immunology , Sheep/immunology , Vaccination/methods , Abomasum/immunology , Abomasum/parasitology , Adjuvants, Immunologic/administration & dosage , Animals , Antibodies, Helminth/blood , Antibodies, Helminth/immunology , Antigens, Helminth/genetics , Feces/parasitology , Female , Haemonchus/genetics , Nematode Infections/parasitology , Nematode Infections/veterinary , Parasite Egg Count , Recombinant Proteins/immunology , Sheep/parasitology , Sheep Diseases/parasitology , Sheep Diseases/prevention & control , Time Factors
6.
Vet Parasitol ; 211(1-2): 54-9, 2015 Jun 30.
Article in English | MEDLINE | ID: mdl-25997645

ABSTRACT

Gene encoding a somatic protein of Haemonchus contortus (Hc23) known to confer significant protection against experimental haemonchosis has been cloned and expressed in a prokaryotic system. A cDNA library of H. contortus using the vector λ ZAP II was obtained. Full-length gene was amplified, cloned and expressed in Escherichia coli BL21. The recombinant protein was purified in Ni-NTA column. Recombinant protein (rHc23) had 203 aminoacids and a molecular mass of 24.15 kDa. Recombinant protein (100 µg/dose) with aluminum hydroxide as adjuvant was administered to 5-6 months age female Assaf lambs on days -42, -28 and -14. On day 0 animals were infected with 15,000 L3 of H. contortus. Vaccination with rHc23 elicited a significant protection against challenge, with >80% reductions in both fecal egg counts and average abomasal parasite burdens at the end of the experiment (45 days post challenge) besides lack of variations in packed cell volume. Results support the feasibility of vaccination against lamb haemonchosis with a recombinant product from an exposed antigen.


Subject(s)
Antigens, Helminth/immunology , Haemonchiasis/veterinary , Haemonchus/immunology , Sheep Diseases/prevention & control , Vaccination/veterinary , Abomasum/parasitology , Adjuvants, Immunologic , Aluminum Hydroxide , Amino Acid Sequence , Animals , Feces/parasitology , Female , Gene Library , Haemonchiasis/parasitology , Haemonchiasis/prevention & control , Male , Molecular Sequence Data , Parasite Egg Count/veterinary , Recombinant Proteins , Sheep , Sheep Diseases/parasitology
7.
Int J Parasitol ; 44(7): 429-36, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24759430

ABSTRACT

A somatic protein from adult Haemonchus contortus (Hc23), the most abundant component in a low molecular weight fraction with known immunizing effect against experimental haemonchosis, has been purified by immunochromatography. The immunoprophylactic value of Hc23 was tested in groups of 5-6 months old Assaf lambs using Al(OH)(3) or Escherichia coli lipopolysaccharide+inactivated Propionibacterium acnes as adjuvant and the results compared with uninfected control, uninfected and challenged or infected and challenged lambs. Immunization with Hc23 in either adjuvant elicited significant reductions in fecal egg counts after challenge with 15,000 L3s (70.67%-85.64%, respectively) and reduced (67.1% and 86%) abomasal worm counts (45 days post-challenge). Immunized lambs displayed higher peripheral eosinophil counts, were less anaemic and had weight gains than challenged controls. The results suggest that the Hc23 antigen can induce a partially protective response against haemonchosis in lambs.


Subject(s)
Haemonchiasis/veterinary , Haemonchus/immunology , Helminth Proteins/immunology , Sheep Diseases/prevention & control , Vaccines/immunology , Amino Acid Sequence , Animals , Antigens, Helminth/chemistry , Antigens, Helminth/genetics , Antigens, Helminth/immunology , Feces/parasitology , Haemonchiasis/parasitology , Haemonchiasis/prevention & control , Helminth Proteins/chemistry , Helminth Proteins/genetics , Parasite Egg Count/veterinary , Sheep , Sheep Diseases/parasitology
8.
Vet Parasitol ; 203(1-2): 231-6, 2014 Jun 16.
Article in English | MEDLINE | ID: mdl-24636785

ABSTRACT

Intestinal helminth infections are common and of paramount economic importance in domestic animals. Available chemotherapy is limited and anthelmintic resistance is widespread in some hosts. This scenario favors the exploration of alternative methods of control, among them immune modulators. The effect of Escherichia coli LPS+Propionibacterium acnes on a primary infection of Heligmosomoides polygyrus (Trichostongyloidea) in mice has been tested. Nematode infection induced a rise of specific IgG1, both serum and intestinal, and a significant reduction in the unspecific (ConA) lymphoproliferative response. Treatment with the immune modulator (days -2, 0, 7 and 14 post infection) elicited an apparent delay of larval intramucosal development. Moreover cumulative nematode egg shedding in treated mice was significantly lower (p=0.0041). Preliminary results point toward the interest of immune modulators to control intestinal helminths.


Subject(s)
Antibody Formation/immunology , Lipopolysaccharides/pharmacology , Propionibacterium acnes/immunology , Strongylida Infections/immunology , Animals , Antibodies, Helminth/analysis , Antibodies, Helminth/blood , Antibody Formation/drug effects , Feces/parasitology , Heligmosomatoidea/immunology , Immunologic Factors/pharmacology , Immunomodulation/immunology , Intestines/parasitology , Intestines/pathology , Larva , Mice, Inbred BALB C , Parasite Egg Count , Parasite Load
9.
Clin Vaccine Immunol ; 20(9): 1352-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23761655

ABSTRACT

Seven 3-month-old, female, helminth-free lambs were immunized intranasally with three doses (1 mg total) of a recombinant part of the catalytic region of the serine/threonine phosphatase 2A (PP2Ar) (group 1 [G1]). In addition, four lambs were used as an adjuvant control group (G2), four as unimmunized, infected controls (G3), and four as unimmunized, uninfected controls (G4). Fifteen days after the last immunization, lambs from G1, G2, and G3 were challenged with 10,000 larval stage 3 (L3) organisms in a plurispecific nematode infection composed of ca. 40% Trichostrongylus colubriformis, 40% Haemonchus contortus, and 20% Teladorsagia circumcincta. All the lambs were clinically monitored throughout the experiment. Parasitological (fecal egg output and immunological response), biopathological (packed-cell volume and leukocyte and eosinophil counts), and zootechnical (live-weight gain) analyses were conducted. On day 105 of the experiment, all the animals were slaughtered and the adult worm population in their abomasa examined. Intranasal administration of PP2Ar with bacterial walls as an adjuvant elicited a strong immune response in the immunized lambs, as evidenced by their humoral immune response. Immunized animals and animals receiving the adjuvant shed significantly (P < 0.001) fewer numbers of parasites' eggs in their feces. The immunization significantly reduced the helminth burden in the abomasa by the end of the experiment (>68%), protection being provided against both Haemonchus and Teladorsagia. Live-weight gain in the immunized lambs was similar to that in the uninfected controls versus the infected or adjuvanted animal groups. Our results suggest that heterologous immunization of ruminants by intranasal administration may be efficacious in the struggle to control gastrointestinal helminths in these livestock.


Subject(s)
Antigens, Helminth/immunology , Intestinal Diseases/veterinary , Nematoda/enzymology , Nematoda/immunology , Nematode Infections/veterinary , Protein Phosphatase 2/immunology , Vaccination/methods , Adjuvants, Immunologic/administration & dosage , Administration, Intranasal , Animals , Antibodies, Helminth/blood , Antigens, Helminth/administration & dosage , Antigens, Helminth/genetics , Bacteria/chemistry , Body Weight , Cell Wall/metabolism , Feces/parasitology , Female , Helminthiasis/prevention & control , Intestinal Diseases/prevention & control , Intestinal Diseases, Parasitic , Nematoda/genetics , Nematode Infections/prevention & control , Parasite Egg Count , Protein Phosphatase 2/administration & dosage , Protein Phosphatase 2/genetics , Recombinant Proteins/administration & dosage , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Sheep
10.
J Microbiol Methods ; 94(2): 111-116, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23707202

ABSTRACT

The value of resazurin-based Alamar Blue redox indicator to determine multiplication of Leishmania promastigotes in 96-well microtiter plates was examined. In addition, assay was validated with amphotericin B (AmB) and allicin. The method was tested on L.donovani and L.infantum promastigotes under different culture conditions (variable air-phase, presence of phenol red, initial cell density, incubation time, use of Hepes buffer). Results showed that the gas-phase of promastigote cultures was critical. The method yielded consistent results with initial plating cell densities of 2.5 × 105 promastigotes/well, up to 72 h incubation and 5% CO2 atmosphere or reduced air availability (sealed plastic bags, film-sealed microplates). Detection of low numbers of promastigotes and earlier results could be obtained using fluorimetry instead of spectrophotometry. The addition of 20 mM Hepes improved the results. Fluorescence intensity correlated to promastigotes number in both Leishmania spp. Inhibitory concentration (IC50) values for AmB and allicin using cell counting and fluorimetry were comparable. Under these conditions this one-step, low-cost redox indicator can be used in drug sensitivity assays and studies of differential proliferation rates of Leishmania isolates or strains in a 96-well format.


Subject(s)
Leishmania/growth & development , Leishmaniasis/parasitology , Leishmaniasis/veterinary , Oxazines/metabolism , Parasitology/methods , Xanthenes/metabolism , Animals , Cell Proliferation/drug effects , Dog Diseases/diagnosis , Dog Diseases/parasitology , Dogs , Humans , Leishmania/drug effects , Leishmania/metabolism , Leishmaniasis/diagnosis , Oxazines/pharmacology , Parasitology/instrumentation , Xanthenes/pharmacology
11.
Vet Med Int ; 2010: 852146, 2010.
Article in English | MEDLINE | ID: mdl-20631899

ABSTRACT

Haemonchosis, caused by the abomasal nematode Haemonchus contortus, is a common parasitic disease of sheep. Our previous results showed that a soluble fraction from adult stages of the nematode (p26/23) induced partial protection against challenge. Recombinant DNA technology was applied to obtain a synthetic protein (rHcp26/23). Immunological assays (ELISA, Western blotting, and immunolocalization), using sera from lambs immunized with p26/23, confirmed the identity of the recombinant protein and demonstrated that the synthetic protein is equivalent to the purified protein employed in the previous immunoprophylaxis studies. Vaccination of lambs with 300 mug of rHcp26/23 and Freund's adjuvant elicited a notable specific antibody response. Immunization did not induce any significant protection after challenge with 16000 infective larvae of H. contortus, and comparable values for parasite faecal egg output, packed cell volume, and abomasal parasite burdens were found in vaccinated and control animals.

12.
Rev. cient. (Maracaibo) ; 17(6): 577-587, nov.-dic. 2007.
Article in English | LILACS | ID: lil-548564

ABSTRACT

La hemoncosis, causada por el nematodo del abomaso de rumiantes Haemonchus contortus, constituye una de las enfermedades parasitarias más notables del ganado ovino en todo el mundo. Las infecciones provocan síndromes anémicos y de mala digestión/absorción que pueden causar la muerte en los casos agudos y disminución de la producción en las formas crónicas. Las claves principales para la aparición de esta enfermedad son el comportamiento biológico del helmito, su patogenia, además de la respuesta del hospedador. El conocimiento actualizado de estos aspectos permitirá una mayor eficaciencia de los métodos de diagnóstico y contro del proceso y, como consecuencia, la disminución de los riesgos de aparición de esta enfermedad. La presente revisión analiza y discute algunos aspectos de la relación ganado ovino-H. contortus de interés para disminuir el impacto de esta parasitosis sobre la salud y producción ganaderas.


Haemonchosis, caused by the abomasal nematode Haemonchus contortus, is among the most relevant parasitic diseases of small ruminants all over the world. The infections are responsible for anemic and bad digestion/absorption syndromes causing the death of severely infected animals in acute cases and the reduction of production scores in the chronic forms of the disease. The keys for the appearance of the disease include the biological behavior of the helminth and mechanisms of pathogenesis, besides the host’s response. The updated knowledge of these aspects would result in a higher efficiency of diagnostic and control methods, thus reducing the risks of appearance of the disease. In the present review, several aspects of the sheep - H. contortus relationship are analyzed with the aim of reducing the impact of this parasitosis on livestock health and productivity.


Subject(s)
Animals , Digestion , Parasitic Diseases, Animal/pathology , Haemonchus/pathogenicity , Haemonchiasis/parasitology , Haemonchiasis/veterinary , Sheep/parasitology , Parasitology , Veterinary Medicine
SELECTION OF CITATIONS
SEARCH DETAIL
...